Cargando…
Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system
A key challenge in the field of therapeutic viral vector/vaccine manufacturing is maximizing production. For most vector platforms, the ‘benchmark' vector titres are achieved with inert reporter genes. However, expression of therapeutic transgenes can often adversely affect vector titres due to...
Autores principales: | Maunder, H. E., Wright, J., Kolli, B. R., Vieira, C. R., Mkandawire, T. T., Tatoris, S., Kennedy, V., Iqball, S., Devarajan, G., Ellis, S., Lad, Y., Clarkson, N. G., Mitrophanous, K. A., Farley, D. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378976/ https://www.ncbi.nlm.nih.gov/pubmed/28345582 http://dx.doi.org/10.1038/ncomms14834 |
Ejemplares similares
-
Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo
por: Ellis, Scott, et al.
Publicado: (2012) -
Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD
por: Iqball, Sharifah, et al.
Publicado: (2023) -
A TRiP to the plasma membrane
por: Ghosh, Debapriya, et al.
Publicado: (2015) -
Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR
por: Christodoulou, I, et al.
Publicado: (2016) -
Drosophila pVALIUM10 TRiP RNAi lines cause undesired silencing of Gateway-based transgenes
por: Stanković, Dimitrije, et al.
Publicado: (2022)